newest glp-1 Professor Receives Grant to Study Effectiveness of Weight-Loss Drugs Great before or with a meal to increase satiety Retatrutide for weight loss: Study

Gastaldelli A, Repetto E, Guja C et al (2020) Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

The period when one medication is washing out and the other has not yet reached therapeutic levels creates a window of reduced glycemic control

The first wave of generic versions of Novo Nordisk's GLP-1 weight-loss drugs launched in India over the weekend, with at least five domestic drugmakers undercutting the original price by up to 80%

This new study adds to a growing body of evidence that GLP-1 medicines may play a role in lowering dementia risk. After applying matching methods to control for confounding factors, the study included over 174,000 patients, evenly divided between the two treatment groups

However, the lack of FDA approval and oversight for the final compounded products introduces inherent risks. Douglas Ewing, MD, FACS, DABOM Concerns have been raised about the potential for contamination, impurities, and incorrect dosages in some compounded products, Ewing continued